$AVDL News Article - Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ(TM) (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Adults Living with Narcolepsy
https://marketwirenews.com/news-releases/avad...69744.html